Stay updated on Nemvaleukin+Pembrolizumab in Platinum-Resistant Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Nemvaleukin+Pembrolizumab in Platinum-Resistant Ovarian Cancer Clinical Trial page.

Latest updates to the Nemvaleukin+Pembrolizumab in Platinum-Resistant Ovarian Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page history now shows Revision: v3.3.2 added and Revision: v3.3.1 deleted.SummaryDifference0.1%

- Check21 days agoChange DetectedThe page shows a new revision entry (v3.3.1) and removal of an older revision (v3.2.0); these are internal versioning updates and do not affect the trial data or displayed content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check29 days agoChange DetectedRemoval of the generic government funding/operating-status notice from the page. This does not affect the study record history or core content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check43 days agoChange DetectedNew version includes updates to core trial status fields (Study Status and Recruitment Status) in the history, reflecting current changes to the trial's state.SummaryDifference0.1%

- Check71 days agoChange Detected- Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.SummaryDifference11%

- Check79 days agoChange DetectedUpdate: version bump from v3.0.2 to v3.1.0. No substantive content changes detected.SummaryDifference0.3%

Stay in the know with updates to Nemvaleukin+Pembrolizumab in Platinum-Resistant Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nemvaleukin+Pembrolizumab in Platinum-Resistant Ovarian Cancer Clinical Trial page.